Everything below concerns blood-brain barrier. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-08-30. Numbers and descriptions here follow the published literature rather than marketing material.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its four N-terminal residues reproduce tuftsin, a tetrapeptide fragment of the immunoglobulin heavy chain, while the C-terminal Pro-Gly-Pro extension is a synthetic addition. The peptide has a molecular mass near 752 daltons and carries a net positive charge at physiological pH because of the arginine and lysine side chains. Published indexes list it under the name Selank and the sequence abbreviation TKPRPGP. Solid-phase peptide synthesis is the standard production route for research quantities.
Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | Tuftsin analogue with a C-terminal Pro-Gly-Pro tail |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Abbreviated TKPRPGP in most catalogues |
| Molecular mass | About 752 Da | Value for the free peptide |
| Solubility | Freely soluble in water | Aqueous solutions are kept cold and used promptly |
| Typical storage | -20 °C, dry, protected from light | Applies to the lyophilised powder before reconstitution |
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
Democrats had differing views on why Harris lost the election. Vermont Senator Bernie Sanders blamed Democrats for having abandoned the working class. Democratic National Committee chair Jaime Harrison dismissed Sanders' criticism. Former House Speaker Nancy Pelosi also disagreed with Sanders, blaming the party's loss on Biden's late exit and the lack of an open Democratic primary. Senator Chris Murphy (D-CT) believed that the Democrats could not connect to a large number of voters and should embrace populism going forward. Representative Ritchie Torres (D-NY) attributed Trump's victory to public discontent over inflation and immigration; he asserted that Harris ran an effective campaign, but could not overcome a difficult electoral environment.
Until the early 1990s, the PLA Navy (PLAN) performed a subordinate role to the PLA Ground Force (PLAGF). Since then it has undergone rapid modernisation. The 300,000 strong PLAN is organized into three major fleets: the North Sea Fleet headquartered at Qingdao, the East Sea Fleet headquartered at Ningbo, and the South Sea Fleet headquartered in Zhanjiang. Each fleet consists of a number of surface ship, submarine, naval air force, coastal defence, and marine units. The navy includes a 25,000 strong Marine Corps (organised into seven brigades), a 18,000 strong Naval Aviation Force operating several hundred attack helicopters and fixed-wing aircraft. As part of its overall programme of naval modernisation, the PLAN is in the stage of developing a blue water navy. In November 2012, then Party General Secretary Hu Jintao reported to the CCP's 18th National Congress his desire to "enhance our capacity for exploiting marine resource and build China into a strong maritime power". According to the United States Department of Defense, the PLAN has numerically the largest navy in the world. The PLAN is led by Commander Hu Zhongming and Political Commissar is currently vacant.
== Reproduction == Corals can be both gonochoristic (unisexual) and hermaphroditic, each of which can reproduce sexually and asexually. Reproduction also allows coral to settle in new areas. Reproduction is coordinated by chemical communication.
=== Brand names === Other brand names include Zadex (Hungary), Rheutrop (Austria), Acemetadoc, Acephlogont, Azeat, Rantudil (Germany, Hungary, Mexico, Poland, Portugal, Turkey), Gamespir (Greece), Oldan, Reudol (Spain), Tilur (Switzerland), ACEO (Taiwan), Ost-map (Egypt).
Many exercises are partially aerobic and anaerobic; for example, soccer and rock climbing. The presence of lactic acid has an inhibitory effect on ATP generation within the muscle. It can even stop ATP production if the intracellular concentration becomes too high. However, endurance training mitigates the buildup of lactic acid through increased capillarization and myoglobin. This increases the ability to remove waste products, like lactic acid, out of the muscles in order to not impair muscle function. Once moved out of muscles, lactic acid can be used by other muscles or body tissues as a source of energy, or transported to the liver where it is converted back to pyruvate. In addition to increasing the level of lactic acid, strenuous exercise results in the loss of potassium ions in muscle. This may facilitate the recovery of muscle function by protecting against fatigue. Delayed onset muscle soreness is pain or discomfort that may be felt one to three days after exercising and generally subsides two to three days later. Once thought to be caused by lactic acid build-up, a more recent theory is that it is caused by tiny tears in the muscle fibers caused by eccentric contraction, or unaccustomed training levels. Since lactic acid disperses fairly rapidly, it could not explain pain experienced days after exercise. A meta-analysis of 15 studies compared the average number of steps walked per day to the risk of mortality, both for adults over 60 years old and for adults under 60 years old.
Sources: en.wikipedia.org
=== Australia and New Zealand === Mitragyna speciosa is a prohibited substance in Australia. In New Zealand, Mitragyna speciosa is designated a prescription medicine, and its use in herbal remedies is prohibited under section 2 of the Medicines Act 1981.
It is the country's second-largest private employer and the third-largest employer overall. The United States is home to over 220 Michelin-starred restaurants, 14 of which were awarded three stars. Wine has been produced in what is now the United States since the 1500s, with the first widespread production beginning in what is now New Mexico in 1628. In the modern U.S., wine production is undertaken in all fifty states, with California producing 84 percent of all U.S. wine. With more than 1,100,000 acres (4,500 km2) under vine, the United States is the fourth-largest wine-producing country in the world, after Italy, Spain, and France. The classic American diner, a casual restaurant type originally intended for the working class, emerged during the 19th century from converted railroad dining cars made stationary. The diner soon evolved into purpose-built structures whose number expanded greatly in the 20th century. The American fast-food industry developed alongside the nation's car culture. American restaurants developed the drive-in format in the 1920s, which they began to replace with the drive-through format by the 1940s. American fast-food restaurant chains, such as McDonald's, Burger King, Chick-fil-A, Kentucky Fried Chicken, Dunkin' Donuts and many others, have numerous outlets around the world.
A common substrate used in this type of system is glass. Depending if the system is open or closed, there would be either one or two layers of glass. The bottom layer of the device contains a patterned array of individually controllable electrodes. When looking at a closed system, there is usually a continuous ground electrode found through the top layer made usually of indium tin oxide (ITO). The dielectric layer is found around the electrodes in the bottom layer of the device and is important for building up charges and electrical field gradients on the device. A hydrophobic layer is applied to the top layer of the system to decrease the surface energy where the droplet will actually be in contact with. The applied voltage activates the electrodes and allows changes in the wettability of droplet on the device's surface. In order to move a droplet, a control voltage is applied to an electrode adjacent to the droplet, and at the same time, the electrode just under the droplet is deactivated. By varying the electric potential along a linear array of electrodes, electrowetting can be used to move droplets along this line of electrodes. Modifications to this foundation can also be fabricated into the basic design structure. One example of this is the addition of electrochemiluminescence detectors within the indium tin oxide layer (the ground electrode in a closed system) which aid in the detection of luminophores in droplets. In general, different materials may also be used to replace basic components of a DMF system such as the use of PDMS instead of glass for the substrate.
=== Vertical transmission === In the case of some diseases such as AIDS and hepatitis B, it is possible for the offspring of infected parents to be born infected. This transmission of the disease down from the mother is referred to as vertical transmission. The influx of additional members into the infected category can be considered within the model by including a fraction of the newborn members in the infected compartment.
=== April === 3 April – Ted Hipkiss, cricketer (Northern Districts) (born 1947). 5 April Raymond Hawthorne, actor (Mortimer's Patch, Bread and Roses, Shortland Street) and theatre director (Mercury Theatre, National Opera of New Zealand) (born 1936). Di McCarthy, behavioural neuroscientist (University of Auckland), chief executive of the Royal Society of New Zealand Te Apārangi (2007–2014). 6 April Sue Berry, physiotherapist and businesswoman, co-founder of Whitestone Cheese (1987) (born 1944). Avis Fletcher, Olympic hurdler and sprinter (1964), British Empire and Commonwealth Games double bronze medallist (1962) (born 1938). 9 April Nancy Carr, home economist (University of Otago) (born 1936). John Mayhew, sports physician (All Blacks, North Harbour, New Zealand Warriors) (born 1954). 11 April – Robyn Kahukiwa, artist, children's writer and illustrator, Te Tohu mō Te Arikinui Dame Te Atairangikaahu (2020) (born 1938). 13 April John Bradshaw, geologist (University of Canterbury), Fellow of the Royal Society of New Zealand (since 1999) (born 1939). David Kernohan, architect and academic (Victoria University of Wellington) (born 1947). 14 April – Peter Matheson, theologian (University of Otago) (born 1938). 16 April – Roger McLachlan, rock bassist (Little River Band) (born 1954). 18 April – Bill Woods, local politician and community leader, Mayor of Selwyn (1992–1995) (born 1942). 19 April – Peter Hilt, politician, MP for Glenfield (1990–1996) (born 1942).
Sources: en.wikipedia.org
Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.
Tuftsin is a natural tetrapeptide derived from the Fc portion of immunoglobulin G. Selank retains that tetrapeptide at its N-terminus and adds three residues to improve resistance to enzymatic breakdown. The relationship is structural, and the two molecules are not interchangeable in experimental work.
It holds a product registration in Russia for intranasal use as an anxiolytic. Registrations of that kind are not automatically accepted by regulators elsewhere. In most other countries it is treated as an unapproved substance or a research material.
The most common approach combines reverse-phase liquid chromatography with mass spectrometry. Chromatography separates the components while mass spectrometry confirms the molecular mass. Peptide sequencing or tandem mass analysis can further verify the amino acid order.